Inner Mongolia Furui Medical Science
Launch date
Employees
Market cap
$1.3b
Enterprise valuation
$1.3b (Public information from Sep 2024)
Share price
CNY35.33 300049.SZ
Beijing China (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 808m | 898m | 1.0b | 1.2b | 1.6b | 2.2b | 2.8b |
| % growth | (3 %) | 11 % | 12 % | 14 % | 37 % | 36 % | 28 % |
| EBITDA | 199m | 271m | 274m | 315m | 359m | 530m | 719m |
| % EBITDA margin | 25 % | 30 % | 27 % | 27 % | 23 % | 25 % | 26 % |
| Profit | 61.9m | 95.5m | 97.9m | 102m | 203m | 307m | 430m |
| % profit margin | 8 % | 11 % | 10 % | 9 % | 13 % | 14 % | 16 % |
| EV / revenue | 2.6x | 4.2x | 6.4x | 9.9x | 7.1x | 5.2x | 4.0x |
| EV / EBITDA | 10.5x | 13.9x | 23.4x | 36.4x | 31.3x | 21.2x | 15.6x |
| R&D budget | 65.8m | 64.8m | 70.8m | 82.5m | - | - | - |
| R&D % of revenue | 8 % | 7 % | 7 % | 7 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
